Cereno Scientific are active within biotechnology. Today, the company is focused on developing pharmaceuticals for the treatment of various cardiovascular diseases. The products are used to treat potential blood clots that may lead to stroke, myocardial infarction, pulmonary embolism, as well as venous thrombosis. The company was founded in 2012 and is based in Gothenburg.

Quotes for Cereno Scientific AB

Right Now

+/-
0.08
%
2,27%
Latest
3.6
High
3.75
Low
3.5
Volume
698 032
Turnover (SEK)
2 515 833
Value (MSEK)
144,3

Board

CEO

  • Sten R Sörensen

Chairman Of The Board

  • Catharina Bäärnhielm

Board

  • Anders Svensson
  • Björn Dahlöf
  • Jonas Faijerson Säljö
  • Klementina Österberg
  • Sverker Jern

Videos

Largest Owners

Name Capital % Votes % Date
Niklas Bergh 6,05 12,58 2019-06-07
GU Ventures 4,81 3,67 2019-06-30
Avanza Pension 4,17 3,18 2019-06-30
Kjetil Myrlid Aasen 3,54 2,70 2019-06-30
Sverker Jern 3,04 7,10 2019-06-30
Pia Larsson 2,91 2,22 2019-06-30
Ivar Nordqvist 2,81 2,15 2019-06-30
Staffan Eriksson 2,39 1,82 2019-06-30
Björn Dahlöf 2,38 4,44 2019-06-30
Jonas Säljö 2,17 4,47 2019-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Inquiry Financial

Upcoming reports

  • 2019-08-30 Delårsrapport 2019-Q2

  • 2019-11-14 Delårsrapport 2019-Q3

  • 2020-02-27 Bokslutskommuniké 2019